author-photo

D.V. Trukhin

Odessa National Medical University

2

Papers

478

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Patient-reported outcomes with first-line durvalumab plus platinum-etoposide versus platinum-etoposide in extensive-stage small-cell lung cancer (CASPIAN): a randomized, controlled, open-label, phase III study.

2020 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (10)
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

2019 The Lancet
Show All
- Source
- Cite
- Save
Citations (468)